Lasa Supergenerics (LASA)₹4.78−4.97%Pharmaceuticals
At the end of the Mar 2026 quarter, Lasa Supergenerics' shareholders were: promoters 53.59%, public 46.41%. Promoter holding is unchanged on the quarter. 20.69% of promoter shares were pledged. It had 27,707 shareholders.
As of · Company filings (shareholding pattern)
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 53.59% | 53.59% | 53.59% | 53.59% | 53.59% | 53.59% | 53.59% | 53.59% | 53.59% | 53.59% | 53.59% | 53.59% |
| FIIs | 0.00% | 0.00% | 0.01% | 0.12% | 0.00% | 0.01% | 0.00% | 0.00% | 0.47% | 0.00% | 0.00% | 0.00% |
| Public | 46.41% | 46.41% | 46.40% | 46.29% | 46.41% | 46.40% | 46.41% | 46.41% | 45.94% | 46.41% | 46.41% | 46.41% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 20.69% |
| Number of shareholders | 28,037 | 27,776 | 27,166 | 27,620 | 27,222 | 27,974 | 27,277 | 27,193 | 28,121 | 28,662 | 28,126 | 27,707 |
| Holder | Category | Mar 2026 | Change (pp) |
|---|---|---|---|
| Omkar Pravin Herlekar | Promoter | 53.62% | 0.00 |
| Mahendra Girdharilal Wadhwani | Public | 1.01% | 0.00 |
Promoters held 53.59% of Lasa Supergenerics at the end of the Mar 2026 quarter, the same as a year earlier.
In the Mar 2026 quarter, foreign institutional investors (FIIs) held 0.00% (unchanged at 0.00% a quarter earlier) and domestic institutions (DIIs) held no reported stake.
Yes. 20.69% of promoter shares were pledged at the end of the Mar 2026 quarter.
Lasa Supergenerics had 27,707 shareholders at the end of the Mar 2026 quarter, against 27,193 a year earlier.
Mahendra Girdharilal Wadhwani (Public) held 1.01% at the end of the Mar 2026 quarter, the largest named holding outside the promoter group.